logo

For the Inventor, By the Inventor

Neustadt am Rübenberge, Germany

Martin Wischniewski

This inventor holds 6 USPTO granted patents. Top assignee: Kali-Chemie Pharma Gmbh. Active years: 1980-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Wischniewski. Retrieved from https://idiyas.com/inventor/martin-wischniewski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 4

Forward Citations = 228(Granted Patents)


Location History:

  • Neustadt, DE (1981 - 1982)
  • Neustadt a. Rbge., DE (1980 - 1988)
  • Neustadt/Rbge., DE (1990)

Company Filing History:

goldMedal6 out of 92 
 
Kali-Chemie Pharma Gmbh
 patents

Years Active: 1980-1990

Loading Chart...
6 patents (USPTO):Explore Patents
1. 4976965 - Coronary affecting medicinal composition (1990-12-11),
2. 4722941 - Readily absorbable pharmaceutical compositions of per se poorly (1988-02-02),
3. 4313930 - Stable valepotriate compounds and process for their preparation (1982-02-02),
4. 4280971 - Process for the production of pancreatin pellets (1981-07-28),
5. 4263313 - Topical pharmaceutical formulations, carrier compositions therefor, and (1981-04-21),
6. 4202888 - Readily enterally absorbable pharmaceutical compositions of cardiac (1980-05-13),

Title: Martin Wischniewski: Innovator in Pharmaceutical Compositions

Introduction

Martin Wischniewski is a notable inventor based in Neustadt am Rübenberge, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work primarily focuses on developing innovative medicinal compositions that enhance the absorption of pharmacologically active agents.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Coronary Affecting Medicinal Composition." This patent describes compositions that include a coronary affecting substance, such as isosorbide nitrates and dihydropyridines, combined with an alkylene glycol ether as a solvent. Another notable patent is for "Readily Absorbable Pharmaceutical Compositions of Per Se Poorly Absorbable Agents." This invention presents a formulation that enhances the absorption of pharmacologically active agents, making it suitable for various applications, including cardiac glycosides, steroids, and antibiotics.

Career Highlights

Martin Wischniewski is currently associated with Kali-Chemie Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new formulations that improve drug efficacy and patient outcomes.

Collaborations

Throughout his career, Martin has collaborated with esteemed colleagues, including Lutz Feicho and Theodor Eckert. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Martin Wischniewski stands out as a prominent inventor in the pharmaceutical industry, with a focus on enhancing drug absorption and efficacy. His contributions through his patents reflect his commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…